共 46 条
- [31] Effect of Tandem Autologous Stem Cell Transplant vs Single Transplant on Event-Free Survival in Patients With High-Risk Neuroblastoma A Randomized Clinical TrialJAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2019, 322 (08): : 746 - 755Park, Julie R.Kreissman, Susan G.London, Wendy B.Naranjo, ArleneCohn, Susan LernerHogarty, Michael D.Tenney, Sheena C.Haas-Kogan, DaphneShaw, Peter JohnKraveka, Jacqueline M.Roberts, Stephen S.Geiger, James DuncanDoski, John J.Voss, Stephan D.Maris, John M.Grupp, Stephan A.Diller, Lisa
- [32] Reduced Bleeding Complications and Increased Event-free Survival With Femoral Vascular Closure Device Use and Bivalirudin in STEMI Patients Undergoing Primary Angioplasty in the HORIZONS-AMI TrialJOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 62 (18) : B95 - B95Sanborn, Timothy A.Mehran, RoxanaGenereux, PhilippeWitzenbichler, BernhardBrener, SorinKirtane, Ajay J.McAndrew, TomFrancese, DominicKornowski, RanDudek, DariuszNikolsky, EugeniaStone, Gregg
- [33] Extrapolating Long-term Event-Free and Overall Survival With Dapagliflozin in Patients With Heart Failure and Reduced Ejection Fraction An Exploratory Analysis of a Phase 3 Randomized Clinical TrialJAMA CARDIOLOGY, 2021, 6 (11) : 1298 - 1305Docherty, Kieran F.Jhund, Pardeep S.Claggett, BrianFerreira, Joao PedroBengtsson, OlofInzucchi, Silvio E.Kober, LarsKosiborod, Mikhail N.Langkilde, Anna MariaMartinez, Felipe A.Ponikowski, PiotrSabatine, Marc S.Sjostrand, MikaelaSolomon, Scott D.McMurray, John J. V.
- [34] Effects of supplementation with a branched-chain amino acid-enriched preparation on event-free survival and quality of life in cirrhotic patients with hepatocellular carcinoma: A multicenter, randomized controlled trialGASTROENTEROLOGY, 2006, 130 (04) : A497 - A497Kobashi, HaruhikoMorimoto, YouichiIto, ToshioShimoe, ToshinanMakino, YasuhiroAraki, YasuyukiIkeda, HiroshiTakaguchi, KouichiAndo, MasaharuMiyake, MasanobuIwasaki, YoshiakiSakaguchi, KohsakuShiratori, Yasushi
- [35] Proportion of long-term event-free survivors and lifetime of adult patients not cured after a standard acute lymphoblastic leukemia therapeutic program - Adult Acute Lymphoblastic Leukemia-94 TrialCANCER, 2007, 109 (10) : 2058 - 2067Le, Quoc-HungThomas, XavierEcochard, ReneIwaz, JeanLheritier, VeroniqueMichallet, MauricetteFiere, Denis
- [36] Randomized Phase II Trial on Primary Chemotherapy with High-Dose Methotrexate Alone or Associated with High-DoseCytarabine for Patients with Primary CNS Lymphoma (IELSG #20 Trial): Tolerability, Activity and Event-Free Survival AnalysisBLOOD, 2008, 112 (11) : 218 - 218Ferreri, Andres J. M.Reni, MicheleFoppoli, MarcoMarteili, MaurizioSiakantaris, MarinaFrezzato, MaurizioCabras, Maria GiuseppinaFabbri, AlbertoCorazzelli, GaetanoIlariucci, FiorellaRossi, GiuseppeSoffietti, RiccardoStelitano, CaterinaVallisa, DanieleZaja, FrancescoGelemur, MartaAondio, Gian MarcoAvvisati, GiuseppeBalzarotti, MonicaBrandes, AlbaCosta, Maria JoaoGomez, HenryGuarini, AttilioPinotti, GraziellaRigacci, LuigiUhlmann, CatrinaAngelopoulou, MariaTirindelli, MariaNaso, VirginiaFranzin, AlbertoAnzalone, NicolettaPonzoni, MaurilioZucca, EmanueleCaligaris-Cappio, FedericoCavalli, Franco
- [37] Donor Lymphocytes Depleted of Alloreactive T-Cells (ATIR101) Improve Event-Free Survival (GRFS) and Overall Survival in a T-Cell Depleted Haploidentical HSCT: Phase 2 Trial in Patients with AML and ALLBLOOD, 2016, 128 (22)Roy, Denis-ClaudeLachance, SilvyRoy, JeanWalker, IrwinMaertens, JohanDelisle, Jean-SebastienFoley, Stephen RonanLewalle, PhilippeOlavarria, EduardoSelleslag, DominikRuediger, ManfredVelthuis, JurjenGerez, LisyaRovers, JeroenBonig, HalvardMielke, Stephan
- [38] Excellent event-free survival despite higher incidence of treatment-related toxicity and mortality in Down syndrome (DS) patients with acute lymphoblastic leukemia (ALL) as compared to patients without Down syndrome (NDS): data from the ALL-BFM 2000 trialKLINISCHE PADIATRIE, 2007, 219 (03): : 189 - 189Moericke, A.Zimmermann, M.Mann, G.Schrappe, M.
- [39] PATIENTS WITH PRIMARY BILIARY CHOLANGITIS TREATED WITH LONG-TERM OBETICHOLIC ACID IN A TRIAL-SETTING DEMONSTRATE BETTER EVENT-FREE SURVIVAL OUTCOMES THAN EXTERNAL CONTROLS FROM THE GLOBAL PBC AND UK-PBC STUDY GROUPSGASTROENTEROLOGY, 2022, 162 (07) : S1196 - S1196Perez, C. Fiorella MurilloKowdley, Kris V.Fisher, HollyHiu, ShaunAdekunle, FemiMayne, TracyMalecha, Elizabeth SmootNess, Erikvan der Meer, Adriaan J.Lammers, Willem J.Trivedi, PalakBattezzati, Pier MariaNevens, FrederikBruns, TonyCazzagon, NoraFloreani, AnnarosaMason, Andrew L.Ponsioen, Cyriel Y.Pares, AlbertLondono, MariaInvernizzi, PietroCarbone, MarcoLleo, AnaMayo, Marlyn J.Dalekos, George N.Gatselis, NikolaosThorburn, DouglasVerhelst, XavierGulamhusein, AliyaJanssen, Harry L.Lindor, Keith D.Corpechot, ChristopheJones, Dave E.Mells, GeorgeHirschfield, GideonWason, JamesHansen, Bettina E.
- [40] Indolent Lymphoma and Vitamin D (ILyAD): A Double-Blind, Randomized, Placebo-Controlled Trial to Evaluate the Supplemental Effect of Vitamin D on Event-Free Survival in Patients with Low Tumor Burden Indolent Non-Hodgkin Lymphoma Treated with RituximabBLOOD, 2019, 134Friedberg, Jonathan W.Brady, Michael T.Strawderman, MylaKahl, Brad S.Leonard, John P.Lossos, Izidore S.Flowers, Christopher R.Sutamtewagul, GrerkCohen, Jonathon B.Peterson, Derick R.Nastoupil, Loretta J.